Precision therapies for cancer and rare diseases

At Blueprint Medicines, we work together toward one common goal: to develop breakthrough precision medicines that allow patients to live longer, healthier lives.

Medical professionals

A team within Blueprint Medicines' global Medical Affairs organization is collaborating with research partners to use ‘real-world’ evidence from numerous sources to help providers more quickly identify and diagnose patients with systemic mastocytosis.

Our platform

Our platform

Our world-leading expertise in protein kinases, which are proven drivers of disease, powers the relentless development of transformational medicines. We believe our progress in the clinic reflects the power of our platform to rapidly and reproducibly pursue highly selective kinase medicines against diverse, difficult-to-drug targets.

Read more about our scientific platform

Our commitment to patients

Patients are at the center of Blueprint Medicines’ mission to discover, develop and deliver innovative medicines that address significant medical needs. From conducting rigorous clinical trials and supporting medical research, to successfully registering our medicines with global health authorities and providing a robust U.S. patient support program for our approved medicines through YourBlueprint™, we aim to bring innovative treatments to the greatest number of patients who may benefit, as quickly and responsibly as possible.

Read about our ongoing clinical trials View our policy on early access Find out about our U.S. patient support program, YourBlueprint™ Learn how we support investigator sponsored trials
“Our team is comprised of scientific pioneers with profound expertise in protein kinases and clinical experts in cancer and rare diseases. Together, we aim to rapidly design and develop transformative precision therapies for patients in need.”
Becker Hewes, M.D., Chief Medical Officer